Cargando…
Super-enhancer profiling identifies novel critical and targetable cancer survival gene LYL1 in pediatric acute myeloid leukemia
BACKGROUND: Acute myeloid leukemia (AML) is a myeloid neoplasm makes up 7.6% of hematopoietic malignancies. Super-enhancers (SEs) represent a special group of enhancers, which have been reported in multiple cell types. In this study, we explored super-enhancer profiling through ChIP-Seq analysis of...
Autores principales: | Fang, Fang, Lu, Jun, Sang, Xu, Tao, Yan-Fang, Wang, Jian-Wei, Zhang, Zi-Mu, Zhang, Yong-Ping, Li, Xiao-Lu, Xie, Yi, Wu, Shui-Yan, Chu, Xin-Ran, Li, Gen, Wu, Di, Chen, Yan-Ling, Yu, Juan-Juan, Jia, Si-qi, Feng, Chen-xi, Tian, Yuan-Yuan, Li, Zhi-Heng, Ling, Jing, Hu, Shao-Yan, Pan, Jian |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9288051/ https://www.ncbi.nlm.nih.gov/pubmed/35842703 http://dx.doi.org/10.1186/s13046-022-02428-9 |
Ejemplares similares
-
BRD4 Inhibitor GNE-987 Exerts Anticancer Effects by Targeting Super-Enhancer-Related Gene LYL1 in Acute Myeloid Leukemia
por: Sang, Xu, et al.
Publicado: (2022) -
CEBPG promotes acute myeloid leukemia progression by enhancing EIF4EBP1
por: Jiang, You, et al.
Publicado: (2021) -
BRD4 inhibitor GNE987 exerts anti-cancer effects by targeting super-enhancers in neuroblastoma
por: Chen, Yan-Ling, et al.
Publicado: (2022) -
MicroRNAs of bone marrow mesenchymal stem cell-derived exosomes regulate acute myeloid leukemia cell proliferation and apoptosis
por: Xu, Yi-Chuan, et al.
Publicado: (2020) -
The BRD4 Inhibitor dBET57 Exerts Anticancer Effects by Targeting Superenhancer-Related Genes in Neuroblastoma
por: Jia, Si-Qi, et al.
Publicado: (2022)